Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AASIST: Streptokinase in Acute Stroke
NCT02150785Phase 2Withdrawn
- Sponsor
- University of Alberta
- Start
- Jun 2014
- Primary completion
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 2 trial of streptokinase in ischemic stroke, sponsored by University of Alberta. Planned start Jun 2014; status: withdrawn.
02
Drugs
streptokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02150785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02150785.